Semnur Pharmaceuticals, Inc.
SMNR
$9.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 151.45M | 497.00K | 478.00K | 1.07M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 152.59M | 999.00K | 665.00K | 1.30M | |
| Operating Income | -152.59M | -999.00K | -665.00K | -1.30M | |
| Income Before Tax | -152.59M | -999.00K | -665.00K | -1.30M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -152.59M | -999.00K | -665.00K | -1.30M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -152.59M | -999.00K | -665.00K | -1.30M | |
| EBIT | -152.59M | -999.00K | -665.00K | -1.30M | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | -0.76 | -0.01 | 0.00 | -0.01 | |
| Normalized Basic EPS | -0.47 | 0.00 | 0.00 | 0.00 | |
| EPS Diluted | -0.76 | -0.01 | 0.00 | -0.01 | |
| Normalized Diluted EPS | -0.47 | 0.00 | 0.00 | 0.00 | |
| Average Basic Shares Outstanding | 201.69M | 160.00M | 160.00M | 200.00M | |
| Average Diluted Shares Outstanding | 201.69M | 160.00M | 160.00M | 200.00M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |